Le Lézard
Classified in: Health, Science and technology
Subject: Stock Sale/Buyback

Alpha Cognition Announces Second Closing of Private Placement and Continuation of the Offering


Alpha Cognition Inc. (CSE: ACOG, OTCQB: ACOGF) ("Alpha Cognition" or the "Company") announces that it has completed a second closing pursuant to its previously announced private placement of units of the Company. Pursuant to the second closing, the Company issued 1,596,830 units of the Company at a price of US$0.22 per unit for gross proceeds of US$351,303. Each Unit consists of a common share and a half warrant, with each whole warrant entitling the holder to purchase an additional common share at a price of US$0.31 for a period of three years. The gross proceeds of the offering received to date are US$1.7 million. The Company is continuing the offering of units on the same terms for up to an additional US$4.8 million.

The Company expects to use the net proceeds from the private placement for research and development, general and administrative matters, and working capital. The Company may complete additional closings pursuant to the private placement.

This news release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities in the United States of America. The securities have not been and will not be registered under the United States Securities Act of 1933 (the "1933 Act") or any state securities laws, and may not be offered or sold within the United States or to U.S. Persons (as defined in the 1933 Act) unless registered under the 1933 Act and applicable state securities laws, or an exemption from such registration is available.


These press releases may also interest you

at 11:59
MGI Tech (MGI), a company committed to building core tools and technology to lead life science, today introduced the latest addition to its range of sequencers, the portable and easy-to-use DNBSEQ-E25 platform, for the European and African market. In...

at 11:46
Single Pass, Inc. is proud to announce that its Class II Kronos biopsy closure device has received clearance from the U.S. Food and Drug Administration (FDA). The FDA has determined the device is substantially equivalent to predicate devices...

at 11:40
Everyone in Canada deserve access to the care they need, when they need it most, including children and youth. Palliative care helps improve the quality of life, comfort, and resilience of seriously ill patients and their families, and is a critical...

at 11:35
Trella Health, the leading provider of market intelligence and integrated customer relationship management (CRM) solutions to the post-acute care industry, is excited to announce the addition of Kathy Ford to its executive leadership team as Chief...

at 11:30
Eighty percent of working age American women believe that the U.S. faces a retirement crisis, and 78 percent say the typical worker just can't save enough on their own to guarantee a secure retirement according to a new research infographic from the...

at 11:30
Prevent Blindness, the nation's leading eye health and safety organization, has announced the recipient of the 2024 Jenny Pomeroy Award for Excellence in Vision and Public Health as Mission for Vision (MFV). Erica Shelton, OD, MS, FAAO, Clinical...



News published on and distributed by: